• Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Germany Italy Spain

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    Denmark Greece Hungary Italy Poland Spain

  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    Greece Hungary Romania

  • Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

    Not recruiting

    2 1 1
    Investigated Drugs:
    Spain

  • Long-Term Safety Study of Azacitidine for Patients with Blood Disorders Who Previously Participated in Azacitidine Clinical Trials

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland

  • Study on the Effects of Oral Semaglutide on Bone Health in Patients with Type 2 Diabetes and Low Bone Mass

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Germany Hungary Italy The Netherlands +4

  • Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Italy Poland Spain

  • Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Estonia Norway

powered by